These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23067303)

  • 1. The botulinum toxin LD50 potency assay - another chapter, another mystery.
    Pickett A
    Altern Lab Anim; 2012 Sep; 40(4):221-3. PubMed ID: 23067303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re: Pickett, the botulinum toxin LD50 potency assay — another chapter, another mystery.
    Stephens ML
    Altern Lab Anim; 2012 Dec; 40(6):346-7; author reply 347-8. PubMed ID: 23447844
    [No Abstract]   [Full Text] [Related]  

  • 3. Measurement of botulinum toxin activity: evaluation of the lethality assay.
    Pearce LB; Borodic GE; First ER; MacCallum RD
    Toxicol Appl Pharmacol; 1994 Sep; 128(1):69-77. PubMed ID: 8079356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potency testing of botulinum neurotoxin products.
    Combes RD
    Altern Lab Anim; 2012 Dec; 40(6):343-6; author reply 347-8. PubMed ID: 23447843
    [No Abstract]   [Full Text] [Related]  

  • 5. The Intercostal NMJ Assay: a new alternative to the conventional LD50 assay for the determination of the therapeutic potency of botulinum toxin preparations.
    Huber A; France RM; Riccalton-Banks L; McLaren J; Cox H; Quirk RA; Shakesheff KM; Thompson D; Panjwani N; Shipley S; Pickett A
    Altern Lab Anim; 2008 May; 36(2):141-52. PubMed ID: 18522482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current scientific and legal status of alternative methods to the LD50 test for botulinum neurotoxin potency testing. The report and recommendations of a ZEBET Expert Meeting.
    Adler S; Bicker G; Bigalke H; Bishop C; Blümel J; Dressler D; Fitzgerald J; Gessler F; Heuschen H; Kegel B; Luch A; Milne C; Pickett A; Ratsch H; Ruhdel I; Sesardic D; Stephens M; Stiens G; Thornton PD; Thürmer R; Vey M; Spielmann H; Grune B; Liebsch M
    Altern Lab Anim; 2010 Aug; 38(4):315-30. PubMed ID: 20822324
    [No Abstract]   [Full Text] [Related]  

  • 7. Assay in mice for low levels of Clostridium botulinum toxin.
    Takahashi M; Kameyama S; Sakaguchi G
    Int J Food Microbiol; 1990 Dec; 11(3-4):271-7. PubMed ID: 2149278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replacing the animal testing of botulinum toxin: time to smooth out the wrinkles.
    Balls M
    Altern Lab Anim; 2010 Mar; 38(1):1-2. PubMed ID: 20377300
    [No Abstract]   [Full Text] [Related]  

  • 9. Growing old disgracefully: the cosmetic use of botulinum toxin.
    Bottrill K
    Altern Lab Anim; 2003 Sep; 31(4):381-91. PubMed ID: 15601243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in applying the Three Rs to the potency testing of Botulinum toxin type A.
    Straughan D
    Altern Lab Anim; 2006 Jun; 34(3):305-13. PubMed ID: 16831062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of Clostridium botulinum type A: release of toxin from C. botulinum spores in vitro by leucocytes.
    Suzuki JB; Booth RR; Grecz N
    Res Commun Chem Pathol Pharmacol; 1970 Sep; 1(5):691-711. PubMed ID: 4944551
    [No Abstract]   [Full Text] [Related]  

  • 12. Clostridium botulinum subtype Ba.
    Giménez DF
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):68-72. PubMed ID: 6380157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refinement and validation of an alternative bioassay for potency testing of therapeutic botulinum type A toxin.
    Sesardic D; McLellan K; Ekong TA; Das RG
    Pharmacol Toxicol; 1996 May; 78(5):283-8. PubMed ID: 8737961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of eels (Anguilla anguilla) and carp (Cyprinus carpio) to type C and E botulinum toxin.
    Haagsma J
    Zentralbl Bakteriol Orig A; 1975 Jan; 230(1):59-66. PubMed ID: 1179868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternatives in testing of bacterial toxins and antitoxins.
    Sesardic D
    Dev Biol (Basel); 2002; 111():101-8. PubMed ID: 12678229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different response of the knockout mice lacking b-series gangliosides against botulinum and tetanus toxins.
    Kitamura M; Igimi S; Furukawa K; Furukawa K
    Biochim Biophys Acta; 2005 Jun; 1741(1-2):1-3. PubMed ID: 15919183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic toxicity of botulinum toxin by intramuscular injection in the monkey.
    Scott AB; Suzuki D
    Mov Disord; 1988; 3(4):333-5. PubMed ID: 3211180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin testing on animals is still a Europe-wide issue.
    Taylor K; Gericke C; Alvarez LR
    ALTEX; 2019; 36(1):81-90. PubMed ID: 30303513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potency equivalence of botulinum toxin preparations.
    Hambleton P; Pickett AM
    J R Soc Med; 1994 Nov; 87(11):719. PubMed ID: 7837204
    [No Abstract]   [Full Text] [Related]  

  • 20. Botulinum neurotoxin dose-dependently inhibits release of neurosecretory vesicle-targeted luciferase from neuronal cells.
    Pathe-Neuschäfer-Rube A; Neuschäfer-Rube F; Genz L; Püschel GP
    ALTEX; 2015; 32(4):297-306. PubMed ID: 26389683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.